Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses

Sequence evolution of the hypervariable region 1 (HVR1) in the N terminus of E2/NS1 of hepatitis C virus (HCV) was studied retrospectively in six chimpanzees inoculated with the same genotype 1b strain, containing a unique predominant HVR1 sequence. Immediately after inoculation, all animals contained the same HVR predominant sequence. Two animals developed an acute self-limiting infection. Anti-HVR1 immunoglobulin G (IgG) was produced 40 to 60 days after inoculation and rapidly disappeared after normalization of transaminases. Another chimpanzee, previously infected with human immunodeficiency virus type 1, showed a delayed response to HVR1 epitopes after superinfection with HCV. No sequence variation of HVR1 was observed in these two animals during the transient viremia in the acute phase. Three other chimpanzees developed a chronic HCV infection. During follow up, sequence evolution occurred in two animals and their anti-HVR1 response remained at varying but detectable levels. The first mutations occurred immediately after the production of anti-HVR1 during the acute phase. However, IgM anti-HVR1 was not detectable. Remarkably, HVR1 sequences remained conserved for more than 6 years in another chronically infected animal. This correlated with the complete absence of detectable anti-HVR1 during this period. Seven years after inoculation, anti-HVR1 IgG was produced and coincided with an HVR1 alteration. These results strongly suggest the involvement of neutralizing anti-HVR antibodies in sequence evolution of HVR1 through immune selection.

[1]  N. Kato,et al.  Hypervariable regions in the putative glycoprotein of hepatitis C virus. , 1991, Biochemical and biophysical research communications.

[2]  L. Stuyver,et al.  Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Zuccotti,et al.  Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction , 1990, The Lancet.

[4]  N. Kato,et al.  Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. , 1992, Biochemical and biophysical research communications.

[5]  E. Holmes,et al.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection , 1993, Journal of virology.

[6]  B. Chesebro,et al.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism , 1992, Journal of virology.

[7]  A. Weiner,et al.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution , 1992, Journal of virology.

[8]  A. Zuckerman,et al.  Further evidence of cellular changes associated with non‐a, non‐b hepatitis , 1980, Journal of medical virology.

[9]  S. Mishiro,et al.  The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients , 1992, Hepatology.

[10]  M. Mizokami,et al.  Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. , 1993, Virology.

[11]  A. Weiner,et al.  Sequence variation in hepatitis C viral isolates. , 1991, Journal of hepatology.

[12]  P. Barr,et al.  Genetic organization and diversity of the hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Chesebro,et al.  Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages , 1991, Journal of virology.

[14]  N. Enomoto,et al.  The hypervariable region of the HCV genome changes sequentially during the progression of acute HCV infection to chronic hepatitis. , 1993, Journal of hepatology.

[15]  Miguel Ángel Martínez,et al.  New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. , 1993, The Journal of general virology.

[16]  S. Desai,et al.  Hypervariable 5′‐terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants , 1993, Journal of medical virology.

[17]  N. Kato,et al.  Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: Humoral immune response to hypervariable region 1 , 1994, International journal of cancer.

[18]  Y. Ito,et al.  Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. , 1992, Virology.

[19]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[20]  Matthew J. Brauer,et al.  Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.

[21]  N. Kato,et al.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.

[22]  R H Purcell,et al.  At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Cullen,et al.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.

[24]  E. Holmes,et al.  A proposed system for the nomenclature of hepatitis C viral genotypes , 1994, Hepatology.

[25]  M. Sakamoto,et al.  A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. , 1993, Virology.

[26]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[27]  Giorgio,et al.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Kato,et al.  Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. , 1992, Virus research.

[29]  A. Weiner,et al.  Vaccination of chimpanzees against infection by the hepatitis C virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.

[31]  K. Ching,et al.  A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants , 1993, Journal of virology.

[32]  M. Uhlén,et al.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. , 1989, Nucleic acids research.